← Nazad


Mallone S



Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Anderson LA, Ardanaz E, Bella F, Botta L, Capocaccia R, Comber H, De Angelis R, Dimitrova N, Gatta G, Kaire I, Leinonen MK, Mallone S, Otter R, RARECAREnet working group, Siesling S, Stiller CA, Trama A, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP
Godina: 2017

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]

Autori: Agius D, Amash H, Ardanaz E, Capocaccia R, Chirlaque MD, Colonna M, Dal Maso L, De Angelis R, EUROCARE-5 Working Group, Kowalska A, Larranaga N, Mallone S, Pacini F, Rubió-Casadevall J, Serraino D, Tavilla A, van Dijk BAC, Virdone S
Godina: 2017

(Šekerija M) Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. European journal of cancer. 2015.

Autori: Allory Y, Kiemeney LA, Malats N, Mallone S, Marcos-Gragera R, Vilardell L
Godina: 2015

(Šekerija M) Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. European journal of cancer. 2015.

Autori: Agius D, Ardanaz E, Crocetti E, Gavin A, Mallone S, Robsahm TE
Godina: 2015

(Šekerija M) Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study. European journal of cancer. 2015.

Autori: Baili P, Di Salvo F, Mallone S, Marcos-Gragera R, Santaquilani M, Siesling S
Godina: 2015